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MutagenesisThe E. coli cls open reading frame (ORF) predicts a 54.8 kDa polypeptide, whereas mature cardiolipin (CL)
synthase is 46 kDa. The N-terminal region extending to residue 60 contains several conserved residues but is
not essential for enzyme activity. A deletion mutant that is missing residues 2–60 produces a fully active
protein. These ﬁndings raise the question of why several residues in a region that is not required for enzyme
activity are conserved. Recombinant DNA technology was used to introduce an EYMPE epitope (EE) tag into
the interior of CL synthase. The EE tagged polypeptide retained the biological properties of wild type CL
synthase, including full enzymatic activity. Site-directed mutagenesis was used to alter conserved residues in
the N-terminal region. An EE tagged CL synthase in which Leu-7 and Val-8 were both replaced by Ser
residues retains in vitro activity but loses most of its in vivo activity. Furthermore, the mutant protein has a
higher apparent molecular mass than its parent protein. Taken together, these ﬁndings suggest that
conserved residues L7 and V8 play a role in polypeptide processing, topology, or both.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Escherichia coli (E. coli) cardiolipin synthase (CL synthase)
catalyzes the reversible reaction between two phosphatidylglycerol
molecules to form cardiolipin (CL) and glycerol [1–3]. The E. coli
structural gene encoding CL synthase, cls, is located at min 28.02 of
the E. coli genetic map [4]. The cls gene (GenBank accession numbers
U15986, D38779, U01911 and L12044) has been cloned and placed
under the control of a tac [5] or a T7 promoter [6], enabling over-
expression of the protein. Translation of the 1458-nucleotide E. coli cls
open reading frame should produce a 54.8 kDa polypeptide (486
residues) with two hydrophobic segments at its N-terminus and none
elsewhere [7,8]. These two N-terminal hydrophobic regions are
predicted by TopPred II to be membrane-spanning α-helices com-
prised of residues 5–25 and 36–56 [9,10]. Translation of cls in a
membrane free in vitro assay produces a polypeptidewith amolecular
mass of 53–55 kDa [7]. Mature cardiolipin synthase analyzed by SDS
PAGE migrates with an apparent molecular mass of 46 kDa, which
suggests that it is posttranslationally modiﬁed by removal of
approximately 80 residues [6,11,12]. When 60 residues are deleted
from the C-terminus, CL synthase has no enzymatic activity [13].
In contrast, when the ﬁrst 60 residues are deleted from the
N-terminus, CL synthase retains activity [14]. Taken together, thesep).
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mature CL synthase formation.
Many of the N-terminal residues of CL synthase are conserved in
gram-negative bacteria (Fig. 1). The conservation of these amino acids
is puzzling because the mature protein migrates with an apparent
molecular mass that suggests the ﬁrst 80 or so residues are cleaved
[6,11,12]. One possible explanation for this conservation is that these
residues function as a signal that contains information necessary to
direct CL synthase to the membrane and obtain proper topology with
its catalytic site facing the periplasm [15]. Evidence for a periplasmic
orientation of this enzyme comes from experiments showing that
when wild type E. coli cells deﬁcient in mannitol transport across the
cell membrane are incubated with 600 mM mannitol, two novel
glycerophospholipids, phosphatidylmannitol and bisphosphatidyl-
mannitol are formed [15]. These mannitol glycerophospholipids are
not formed in mannitol transport deﬁcient cls-1 mutants, indicating
that CL synthase is responsible for their synthesis [15].
The primary sequence of the CL synthase N-terminus does not
readily conform to any known signal sequence, yet experimental
evidence conﬁrms that CL synthase is a membrane protein [6,11,12].
Proper insertion into the cell membrane is probably required to ensure
that the catalytic site will be located on the periplasmic side of the
inner membrane. The leader peptidase, another inner membrane
associated protein that has its catalytic site in the periplasmic space
[16] may be an instructive model when considering CL synthase
orientation in the cell membrane. Two hydrophobic N-terminal
segments of the leader peptidase are embedded in the cell membrane.
Comparison of the N-terminal bacterial CL synthase sequence with
Fig. 1. The ﬁrst 60 amino acid residues of E. coli CL synthase. Conserved residues are
shown as white letters in a black background. Residues that are similar are shown as
black letters in a gray background. The ﬁrst and second transmembrane regions
are predicted to extend from Y5 to L25 and S36 to L56, respectively [9,10]. Resi-
due conservation was determined by CLUSTALW analysis of the following gram-
negative bacteria: Escherichia coli, Planctomyces maris, Desulfotalea psychrophila,
Vibrio campbellii, Yersinia pestis, Buchnera sp., Pseudomonas putida, Pseudomonas
aeruginosa, Vibrio cholerae, Xylella fastidiosa, Zymomonas mobilis subsp. mobilis, and
Ureaplasma urealyticum.
Table 1
Bacterial strains used in this study.
Strain Parent Genotype or description Source or reference
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44
relA1 lac [F′ proAB lacIqZΔM15 Tn10 (TetR)]
Product of Stratagene,
La Jolla, CA, USA
BL21 (DE3) F− ompT hsdSB (r−Bm−B), dcm gal (DE3) [17]
DG6 BL21
(DE3)
cls∷Tn10miniTet3 [14]
BQ1 DG6 Plasmid pLysS was introduced into DG6 This study
QC30-15 QC30 MC4100 glpR glpD pssA1
cls∷Tn10 miniTet3;
[8]
Table 2
Plasmids used in this study.
Plasmid Description/mutation Source or reference
pET3 T7 expression vector [17]
pET-23a(+) T7 expression vector containing T7 and 6× His tags Product of Novagen
pLysS Encodes T7 lysozyme that inhibits T7 RNA
polymerase
[39]
pLR3 CL synthase in pET3 [6]
pBQ41 CL synthase N296E This work
pBQ42 CL synthase N296E, I297Y This work
pBQ43 CL synthase N296E, I297Y, F299M (EE tagged) This work
pBQ47 EE tagged CL synthase G59A This work
pBQ70 EE tagged CL synthase KRR30-32TTT This work
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bacteria reveals four conserved residues2: L7, V8, R32 and G59. One or
more of these conserved residues may be required for proper protein
insertion into the cell membrane. Other residues that are conserved in
CL synthase but not present in leader peptidase may be essential for
posttranslational cleavage, because the E. coli leader peptidase is not
modiﬁed in this fashion.
If conserved N-terminal residues are required for N-terminal
cleavage and proper CL synthase insertion in the cell membrane, then
altering these residues should affect cleavage, insertion, or both.
Efforts to study CL synthase processing would be facilitated by the
use of a tagged protein. Attempts to use a C-terminal 6 X Histidine
tag were unsuccessful (B. R. Quigley in The N-terminal sequence of
E. coli CL synthase: function(s) of the conserved residues. Ph.D.
Thesis, City University of New York, 2007). Although the 6 X His
tagged CL synthase is membrane associated, migrates on SDS PAGE at
the predicted molecular mass of the mature protein, and is visible on
western blot using an anti-6 X His antibody, the protein is inactive in
vivo and in vitro. The fact that the inactive fusion protein retains the
C-terminal tag even though it appears to undergo normal post-
translational processing provides further support for the hypothesis
that cleavage takes place at the N-terminus. The present report
describes the construction of an EYMPE epitope (EE) tagged CL
synthase and the use of this tagged protein to study the effects that
altering conserved N-terminal residues have on CL synthase structure
and function.
2. Materials and methods
2.1. Chemicals
Ampicillin, chloramphenicol, ammonium persulfate, magnesium
chloride, isopropyl β-D-thiogalactopyranoside (IPTG), XGAL (5-
bromo-4-chloro-3-indolyl β-D-galactopyranoside), Folin and Ciocal-
teu's phenol reagent, brilliant blue G perchloric acid solution, 5×
concentrate ﬁxing solution, glycerol, Triton® X-100, NZ Amine A
(casein enzymatic hydrolysate), BSA (bovine serum albumin fraction
V), agarose, glycine (electrophoresis grade), SDS (sodium dodecyl
sulfate), phenol, acrylamide:bis-acrylamide (29:1), TEMED (N,N,N′,N′-
tetramethylethylenediamine), EDTA (ethylenediaminetetraacetic acid
disodiumsalt),MOPS (3-[N-morpholino]propanesulfonic acid), TWEEN
20 (polyethylene glycol sorbitanmonolaurate), bromophenol blue, high
molecular mass protein standard, Immobilon™-P 0.45 μm 15×15 cm
PVDF (polyvinylidene diﬂuoride) transfermembranes (Millipore), silica
gel TLC general purpose (silica gel on polyester) plates, Polaroid 667
black and white ﬁlm, Kodak® developer/replenisher, Kodak® ﬁxer/
replenisher, and Kodak® Biomax™ 1 light ﬁlm were purchased from
Sigma-Aldrich, St. Louis, MO. Restriction endonucleases, T4 DNA2 Escherichia coli, Shigella dysenteriae, Salmonella enterica, Enterobacter, Klebsiella
pneumoniae, Serratia proteamaculans, Erwinia carotovora, Photorhabdus luminescens,
and Vibrio harveyi.ligase, calf intestinal phosphatase, and the 1 kb DNA Ladder were
purchased from New England Biolabs, Ipswich, MA. Goat polyclonal
Glu–Glu tag antibody horse radish peroxidase (HRP) conjugate
(1 mg/mL) was purchased from Abcam, Cambridge, MA. The
Western Lightning® Enhanced Chemiluminescence Kit was pur-
chased from PerkinElmer, Waltham, MA. Low melting temperature
agarose was purchased from Invitrogen, Carlsbad, CA. The Quik-
Change® II Site-Directed Mutagenesis Kit was purchased from
Stratagene, La Jolla, CA. The Qiagen Plasmid Midi Kit was purchased
from Qiagen, Valencia, CA. Primers used to introduce mutations in
cls were purchased from Sigma-Genosys, Woodlands, TX. [2-14C]
Acetate was purchased from ICN, Irvine, CA. Millipore 0.45 μm MF-
Millipore™ membrane ﬁlters were from Millipore, Billerica, MA.
Phosphatidyl[2-3H]glycerol was prepared and puriﬁed as previously
described [14]. Ecoscint biodegradable scintillation ﬂuid was a
product of National Diagnostics, Atlanta, GA. Tryptone, yeast extract,
and agar were obtained from Difco Laboratories, Detroit, MI. All
other chemicals were reagent grade or better.
2.2. Bacterial strains, plasmids, and media
Bacterial strains used in this study are listed in Table 1. Plasmids
used in this study are listed in Table 2. LB medium (1% bactotryptone,
0.5% NaCl, and 0.5% yeast extract) was used for most growth
experiments. M9ZB medium [17] was used in IPTG induction
experiments. Strain QC30-15 [8] and its transformants were cultured
at 30 °C. Unless otherwise stated, all other strains were cultured at
37 °C. Ampicillin and chloramphenicol were used at 125 μg/mL
and 20 μg/mL, respectively. Chloramphenicol concentrations were
increased from 20 μg/mL to 40 μg/mL when cultures were incubated
overnight at 37 °C without shaking. Where indicated, IPTG was
added to a ﬁnal concentration of 0.8 mM. Cell growth was monitored
using a Klett-Summerson photometer ﬁtted with a 660 nm ﬁlter.
A Klett unit corresponds to approximately 5×106 cells/mL. CellspBQ72 EE tagged CL synthase LV7-8SS This work
pBQ74a EE tagged CL synthase 2-60 deletion This work
pBQ75a Non-epitope tagged CL synthase 2-60 deletion This work
a Transcription is dependent on the T7 RNA polymerase and translation is under the
control of the pET-23a(+) strong RBS.
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described [18].
2.3. DNA isolation and manipulation, site-directed mutagenesis, and
plasmid construction
2.3.1. DNA isolation and manipulation
Plasmid DNA used for restriction analysis, transformation and
sequencing experiments was obtained from strain XL1-Blue (Strata-
gene) using a Qiagen Plasmid Midi Kit (Qiagen, Valencia, CA)
according to the manufacturer's instructions. Plasmid DNA was
analyzed by absorbance at 260 nm and 280 nm, as well as by
restriction analysis/agarose gel electrophoresis using a 1% agarose
gel with a TAE buffer system [19]. Restriction endonucleases, calf
intestinal phosphatase and T4 DNA ligase were used according to the
manufacturer's instructions. Dual restriction digests were carried out
in buffer with maximum activity for both enzymes according to the
information provided on the manufacturer's website. When either
restriction endonuclease had a BSA requirement, BSA was added to
the assay mixture.
Subcloning was performed by digesting plasmid DNA with the
appropriate endonuclease(s) followed by puriﬁcation of the resulting
fragments with 0.8% low melting temperature agarose gel electro-
phoresis [19]. Nucleotide fragments were extracted from low melting
temperature agarose gel slices using the phenol/chloroform method
of Sambrook et al. [19].
DNA was prepared for sequencing by sodium acetate/ethanol
precipitation [19]. A 2.0 μg sample of plasmid DNA precipitated in this
manner was resuspended in 20 μL of sterile distilled water containing
100 ng of the appropriate sequencing primer. DNA sequencing was
performed by the Massachusetts General Hospital DNA Core Facility
(Center for Computational and Integrative Biology), Cambridge, MA.
Sequencing primer 1 (5′-CAATGGATTGATCTGATGG-3′) was used to
verify the correct introduction of the EE tag into cls. Sequencing
primer 2 (5′-CTATGCAATAACAGAATGGTC-3′) was used to sequence
all mutations to cls resulting in modiﬁcations to the N-terminus of
CL synthase. Sequencing primer 3 (5′-TAATACGACTCACTATAGGG-3′)
was used to conﬁrm the correct 5′ sequences of plasmids pBQ74
and pBQ75.
2.3.2. Site-directed mutagenesis
Restriction sites, frameshift mutations and point mutations were
introduced into E. coli cls using a QuikChange® II Site-Directed
Mutagenesis Kit (Stratagene) according to the manufacturer's instruc-
tions using complementary oligonucleotide primer pairs. Altered
nucleotides are indicated in lowercase letters, inserted nucleotides
in bold, and deletions by underlines in the ﬂanking nucleotides.
The sequence of only one member of each primer pair is shown.
The primers used are as follows: cls_N296E (5′-CCGCCACCACCA-
GATGTCgAgATTATGCCGTTTGAACAGG-3′); cls_I297Y (5′-CCACC
AGATGTCGAGtaTATGCCGTTTGAACAGGC-3′); cls_F299M (5′-GTCG
AGTATATGCCGaTgGAACAGGCCAGCGG-3′); cls_G59A (5′-GCCTA
TCTTGcCGTTGCCGAGCTCCATTTAGGC-3′); cls_frameshift_30 (5′-GCA
TTCTAATGACAACGACGCGCAGTTCCCTCC-3′); cls_recover_33 (5′-
CATTCTAATGACAACGACCGCAGTTCCCTCC-3′); cls_LV7-8SS (5′-
GACAACCGTTTATACGTcGtcGAGTTGGTTGG-3′).
2.3.3. Construction of plasmid pBQ43
Plasmid pBQ43, encoding CL synthase with an internal EYMPME
epitope (EE) tag, was constructed by subjecting plasmid pLR3 to three
rounds of site-directed mutagenesis. (1) Plasmid pLR3 was converted
to plasmid pBQ41 with primer pair cls_N296E, mutating AAT to gAg to
produce an N296E substitution. (2) Plasmid pBQ41 was converted to
plasmid pBQ42 with primer pair cls_I297Y, mutating ATT to taT
to produce an I297Y substitution. (3) Plasmid pBQ42was converted to
pBQ43with primer pair cls_F299M, mutating TTT to aTg to produce anF299M substitution. The correct introduction of the EE epitope into cls
was veriﬁed by DNA sequencing using sequencing primer 1.
2.3.4. Construction of plasmids pBQ47, pBQ70, and pBQ72
Plasmid pBQ47, which codes for an EE tagged CL synthasewith A59
in place of G59, was constructed by site-directed mutagenesis of
plasmid pBQ43 using primer pair cls_G59A to convert GGC to GcC.
Plasmid pBQ70, which encodes an EE tagged CL synthase with a
KRR30-32TTT mutation, was constructed from plasmid pBQ43 in two
steps. (1) Plasmid pBQ64 was formed by subjecting plasmid pBQ43 to
site-directed mutagenesis with primer pair cls_frameshift_30. This step
inserts a C at position-2 of the K30 codon, converting AAA to ACAA.
(2) Plasmid pBQ70 was formed by subjecting plasmid pBQ64 to site-
directedmutagenesiswithprimerpair cls_recover_33. This stepdeletes a
single nucleotide at position-3 of theT32 codon, convertingACGC toACC.
Plasmid pBQ72, which encodes an EE tagged CL synthase with an
LV7-8SS mutation, was constructed by site-directed mutagenesis of
plasmid pBQ43 using primer pair cls_LV7-8SS to convert TGGT to cGtc.
Altered sequences in plasmids pBQ47, pBQ70 and pBQ72 were veriﬁed
by DNA sequencing using sequencing primer 2.
2.3.5. Construction of plasmids pBQ74 and pBQ75
Plasmid pBQ74, which codes for an EE tagged CL synthase missing
amino acid residues 2–60, was constructed as previously described
[14]. Brieﬂy, this construction is as follows. Plasmid pBQ43 was
cleaved with SacI restriction endonuclease and the isolated cls
fragment was inserted into the SacI restriction site of pET-23a(+) to
produce pBQ74. Plasmid pBQ75, which codes for a non-epitope tagged
2–60 deletion mutant was constructed in the same way starting with
pLR3 instead of pBQ43. Sequencing primer 3 was used to conﬁrm the
predicted N-terminal sequence of pBQ74 and pBQ75. The cls gene in
pBQ74 and pBQ75 lacks the E. coli Pcls and ribosome binding site.
Hence, transcription in these constructs is dependent on the T7 RNA
polymerase and translation is controlled by the pET-23a(+) strong
ribosome binding site.
2.4. [2-14C]Acetate incorporation into bacterial glycerophospholipids
The method used to follow [2-14C]acetate incorporation into
glycerophospholipids depended on whether the strain had a plasmid
with a cls gene that was under the control of the cls or T7 promoter.
In the former case, cells from a single repuriﬁed QC30-15 trans-
formant colony were incubated overnight in 1 mL of LB broth with
ampicillin at 30 °C without shaking. The following morning, 50 μL of
the overnight culture were transferred to 10 mL of fresh LB broth
with ampicillin and incubated at 30 °C with shaking at 250 rpm until
a turbidity of 30 Klett units was reached. Then 2.5 μCi of [2-14C]
acetate (4.3 μCi/μmol) were added and the cells cultured a further
2 h with shaking at 30 °C. Glycerophospholipids were isolated using a
modiﬁcation of the Bligh and Dyer method [20] as previously
described [21]. In the latter case, cells from a single repuriﬁed
BQ1 transformant were incubated overnight at 37 °C without shaking
in 1 mL of M9ZB medium supplemented with ampicillin and
chloramphenicol. The following morning, 50 μL of the overnight
culture were transferred to 10 mL of fresh M9ZB medium
supplemented with ampicillin and chloramphenicol and incubated
at 37 °C with shaking at 250 rpm. When the culture reached a
turbidity of 40 Klett units, IPTG was added and incubation continued
for 30 min. Then 2.5 μCi of [2-14C]acetate (4.3 μCi/μmol) were added
and incubation continued for another 2 h. Glycerophospholipids
were isolated as described above.
2.5. Glycerophospholipid analysis
Silica gel on polyester general purpose TLC plates were washed
prior to use with chloroform: methanol (1:1) and dried in air.
Table 3
In vivo activity of the EE tagged CL synthase and related constructs.
Bacterial strain % CL % PG % PE
QC30-15/pET3 0.5 31 68.5
QC30-15/pLR3 19.6 15 65.4
QC30-15/pBQ43 19.4 16 64.6
QC30-15/pBQ47 15.8 19.6 64.6
QC30-15/pBQ70 6.7 26 67.3
QC30-15/pBQ72 4.8 20.7 74.5
BQ1/pBQ74 34.9 3 62.1
BQ1/pBQ75 35.4 3.4 61.2
Activity reported is the percent incorporation of 2-[14C]acetate into each
glycerophospholipid as described in Materials and methods section.
Table 4
In vitro activity of selected constructs.
Bacterial strain % Activity
DG6/pLR3 100
DG6/pBQ43 167
DG6/pBQ70 18
DG6/pBQ72 233
BQ1/pBQ74 183
Strains were induced with 0.8 mM IPTG and crude membrane fractions were prepared
and assayed as described in Materials and methods. Activity was determined as
previously described [6]. Values reported are the results of duplicate assays from 2
separate experiments.
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to use. Chromatography was performed in glass tanks lined with
Whatmann 3MM ﬁlter paper and equilibrated with solvent for 2 h
prior to the start of the experiment. Samples were spotted to the
plates using glass capillary tubes, and chromatographed in a
chloroform:methanol:acetic acid 65:25:8 solvent system [22].
Radioactive glycerophospholipids were detected and quantiﬁed as
previously described [23].
2.6. Ampliﬁcation of gene products
Expression studies were performed in M9ZB medium [17]
supplemented with the appropriate antibiotics. A 50 μL sample of an
overnight culture was transferred to 10 mL of M9ZB mediumwith the
appropriate antibiotic(s) and cells were cultured at 37 °C with shaking
at 250 rpm. When the culture reached a turbidity of approximately
120 Klett units IPTG was added and cells were cultured for an
additional 3 h. Crude membrane and aqueous fractions used in
enzyme activity assays, SDS PAGE, and western blot experiments were
isolated as previously described [6].
2.7. Preparation of SDS whole cell extracts
Whole cells were analyzed for the cls gene product by a slight
modiﬁcation of the method of Studier andMoffat [17] as follows. After
induction with IPTG for 3 h, 0.5 mL of M9ZB cell culture was
centrifuged in an Eppendorf 5414 microfuge at 12,000 rpm for 1 min
at 25 °C. The bacterial pellet was washed once with 0.5 mL of wash
buffer (100 mM Tris–HCl pH 8.0, 10 mM β-mercaptoethanol, 5 mM
EDTA) at 4 °C. Then, thewashed pellet was resuspendedwith vigorous
mixing in 1×SDS sample buffer (50 mM Tris–HCl pH 6.8, 400 mM
β-mercaptoethanol, 2% SDS, 0.1% bromphenol blue, 10% glycerol) [19].
Cells from a 0.5 mL sample of a typical IPTG induced strain with a
turbidity of 250 Klett units were resuspended in 125 μL of 1×SDS
sample buffer. The volume of SDS sample buffer used was adjusted
according to the ﬁnal turbidity of the original cell sample to roughly
normalize the total protein concentrations in different samples.
Samples were heated to 100 °C for 10 min.
2.8. Protein determination
Protein concentrations were determined using the method of
Lowry, as modiﬁed by Peterson [24].
2.9. SDS PAGE
SDS PAGEwas performed using a discontinuous buffer systemwith
a stacking gel at pH 6.8 and a resolving gel at pH 8.8 according to the
method of Laemmli [25]. After treating with ﬁxing solution, gels were
stained using brilliant blue G perchloric acid solution according to the
manufacturer's instructions.2.10. Western blot and chemiluminescence
Protein samples were transferred to Immobilon™-P PVDF mem-
branes (0.45 μm, Millipore) in transfer buffer (25 mM Tris pH 8.3,
192 mM glycine, 20% v/v methanol) as described by Walker [26].
PVDF membranes were blocked for 30 min at room temperature with
gentle agitation in TBST blocking buffer [26] (137 mM NaCl, 15.4 mM
Tris–HCl pH 7.6, 0.15% TWEEN 20, and 5% nonfat dry milk). The anti-
EE HRP-conjugate goat polyclonal antibody was used at a 1:10,000
dilution in blocking buffer for 30 min at room temperature with
gentle agitation. Following incubation with primary antibody, PVDF
membranes were washed twice with TBST (137 mM NaCl, 15.4 mM
Tris–HCl pH 7.6, 0.15% TWEEN 20) [26] for 5 min at room
temperature with gentle agitation, and excess buffer was removed
by blotting the membrane with Whatmann 3MM ﬁlter paper.
Chemiluminescent detection was performed using a PerkinElmer
Western Lightning® Enhanced Chemiluminescence Kit according to
the manufacturer's instruction. Signals were recorded using Kodak®
Biomax™ 1 light ﬁlm.
2.11. In vitro CL synthase assay
Crude cell membranes were examined for the ability to catalyze
the formation of CL using a mixed micelle assay as previously
described [6]. All assays were performed in duplicate at least two
times. The assay was linear with respect to time over a 10 minute
period using 600 ng of crude membrane. The assay was also linear
with respect to concentration of crudemembrane. The speciﬁc activity
of crude membranes obtained from IPTG induced DG6/pLR3 was
similar to that reported previously [6,14].
2.12. Computer analysis of sequence data
BLAST [27,28], TopPred II [10], ClustalW [29], SignalP3.0 [30,31],
iPSORT [32], Translate [33], PeptideMass [34], Antheprot [35–37] and
FinchTV (Geospiza Inc. Seattle, WA) were used to analyze DNA/
Protein sequence data.
3. Results
3.1. Characterization of a CL synthase with an internal EYMPME epitope
(EE) tag
Three of the 6 amino acids that comprise the EE tag [38] are already
present in the correct position in the primary sequence of wild type CL
synthase. The EE tag was introduced into CL synthase by site-directed
mutagenesis (see Materials and methods section). The CL synthase
encoded by pBQ43, the plasmid bearing the modiﬁed cls gene, was
studied as follows: (1) [2-14C]Acetate incorporation into CL in strain
QC30-15/pBQ43 was monitored as described in Materials and
methods. (2) The EE tagged CL synthase produced by IPTG induced
DG6/pBQ43 was analyzed by SDS PAGE, and by western blot using an
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the mixed micelle assay. As shown in Table 3, QC30-15/pBQ43 has the
same in vivo CL synthase activity as QC30-15/pLR3. Furthermore, the
EE tagged protein is membrane bound, has an apparent molecular
mass of 46 kDa, and is readily detected by western blot analysis using
an anti-EE antibody. The wild type enzyme produced by DG6/pLR3
does not react with anti-EE (data not shown). Membranes obtained
from IPTG induced DG6/pBQ43 have greater in vitro activity than
those obtained from IPTG induced DG6/pLR3 (Table 4). The reason for
this increased activity is not known.
3.2. Characterization of the EE tagged CL synthase with a 2–60 deletion
Previous studies showed that CL synthase missing residues 2–60
migrates with an apparent molecular mass of 48 kDa, is membrane
associated and retains activity in vitro but not in vivo [14]. The effect of
deleting residues 2–60 was examined by constructing pBQ74 (EE
tagged Δ2–60).
E. coli strains QC30-15 [8] and XL1 (Stratagene) grow normally
when transformed with pBQ74. However, strain DG6 [(DE3)
cls∷miniTet3] transformants are not viable. The most likely reason
for viability loss is that the low level of T7 RNA polymerase produced
in the absence of IPTG is sufﬁcient to cause the overproduction of CL
synthase derivatives that are toxic to the cell. Therefore, strain BQ1
(DG6/pLysS) was constructed. Cells with plasmid pLysS [39]
produce a low level of T7 lysozyme that is sufﬁcient to inhibit the
low level of T7 RNA polymerase that is produced in the absence of
IPTG in strains such as DG6. As expected, transformants of strain
BQ1 were viable in the absence of IPTG. Strain BQ1/pBQ74 produces
the epitope tagged protein with a deletion extending from residue 2
to 60. The IPTG induced epitope tagged membrane protein migrates
with an apparent molecular mass of 48 kDa when analyzed by
western blot. CL accounted for about 35% of the total radiolabel
when glycerophospholipids isolated from IPTG induced BQ1/pBQ74
cultured in M9ZB medium containing [2-14C]acetate were analyzed
by TLC (Table 3). As expected, this increase in labeled CL was
accompanied by a decrease in labeled phosphatidylglycerol, which is
the substrate for CL synthase [1–3]. Furthermore, membranes
isolated from IPTG induced BQ1/pBQ74 catalyzed CL formation in
vitro (Table 4).
Earlier studies from this laboratory indicated that the deletion of
residues 2–60 from the wild type enzyme resulted in a CL synthase
that functioned, albeit poorly in vitro, but not at all in vivo [14].
Therefore, it was necessary to determine whether the introduction of
the EE tag was responsible for the differences in activity. The plasmid
encoding the non-epitope tagged CL synthase 2–60 deletion mutant,
pDG5 [14], was lost on storage. Hence, an identical plasmid was
constructed following the published method [14]. This new plasmid,
pBQ75, is not epitope tagged. So, its CL synthase product cannot be
seen using the western blot method. However, it can be visualized by
staining with Coomassie Blue. The membrane bound CL synthase
products encoded by pBQ75 and pBQ74 have the same molecular
mass. Strains BQ1/pBQ74 and BQ1/pBQ75 incorporate [2-14C]acetate
into CL to the same extent (Table 3).
3.3. Characterization of an EE tagged CL synthase with a G59A mutation
Site-directed mutagenesis was used to convert G59 in plasmid
pBQ43 to A59 in plasmid pBQ47 as described in the Materials and
methods section.
IPTG induced DG6/pBQ47 produces a membrane associated CL
synthase that migrates with an apparent molecular mass of 46 kDa.
The EE tagged mutant CL synthase encoded by pBQ47 has approxi-
mately 80% of the in vivo activity of the EE tagged CL synthase encoded
by pBQ43 (Table 3). Thus, the G59A mutation has little if any effect on
CL synthase processing or activity.3.4. Characterization of an EE tagged CL synthase with a
KRR30-32TTT mutation
The conserved N-terminal residues R31 and R32 lie adjacent to the
positively charged K30. The three basic residues were converted to
threonine residues, so that K30 could not compensate for the loss of
R31 and R32. The introduction of the TTTsequence into plasmid pBQ43
to form plasmid pBQ70 is described in the Materials and methods
section. IPTG induced DG6/pBQ70 produces a membrane bound CL
synthase that migrates with an apparent molecular mass of 45 kDa,
which is 1 kDa less than the EE tagged CL synthase encoded by pBQ43.
[2-14C]Acetate incorporation studies showed that strain QC30-15/
pBQ70 produces only about 34% as much labeled CL as does strain
QC30-15/pBQ43 (Table 3). Membranes isolated from IPTG induced
DG6/pBQ70 have only 18% of the in vitro CL synthase activity
compared to those isolated from IPTG induced DG6/pLR3 (Table 4).
3.5. Characterization of an EE tagged CL synthase with an
LV7-8SS mutation
The conserved residues L7 and V8 are within the ﬁrst hydrophobic
region of the N-terminus. Plasmid pBQ72, which bears a cls with
an LV7-8SS substitution, was constructed as described in Materials
and methods. The EE tagged protein produced by IPTG induced DG6/
pBQ72 is membrane associated and migrates with an apparent mole-
cular mass 2 kDa greater than that produced by DG6/pBQ43.
Furthermore, QC30-15/pBQ72 incorporates only 23% of labeled
[2-14C]acetate into CL as compared to QC30-15/pBQ43 (Table 3). As
expected, this decrease in CL was accompanied by an increase in
phosphatidylglycerol (Table 3). When analyzed in vitro, the CL
synthase activity of the membrane fraction isolated from DG6/
pBQ72 is greater than that of the membrane fraction isolated from
cells expressing the epitope tagged CL synthase with wild type
N-terminus (DG6/pBQ43) (Table 4).
4. Discussion
Wild type CL synthase encoded by pLR3 migrates on SDS PAGE
with an apparent molecular mass of 46 kDa [6,11,12]. The EE epitope
(EYMPME) tagged CL synthase encoded by pBQ43 migrates with the
same apparent molecular mass as wild type CL synthase, has nearly
identical in vivo activity and is visible by western blot analysis using
an anti-EE antibody. Membranes isolated from IPTG induced DG6/
pBQ43 have greater in vitro activity than those isolated from IPTG
induced DG6/pLR3. Therefore, the EE epitope tag could be used to
study the biological properties of CL synthase, and allowed the
unambiguous identiﬁcation of mutant forms of CL synthase by
western blot analysis.
The EE epitope tagged Δ2–60 CL synthase encoded by pBQ74
remains membrane associated, and retains in vitro and in vivo activity
despite the fact that it is missing the conserved N-terminal residues.
The same is true for the untagged Δ2–60 CL synthase encoded by
pBQ75. It is interesting to note that CL synthases produced by pBQ74
and pBQ75 migrate on SDS PAGE with an apparent molecular mass of
48 kDa, or about 2 kDa greater than CL synthase with a wild type
N-terminus. Therefore, the truncated protein undergoes abnormal
N-terminal cleavage. The results obtained for pBQ74 (EE taggedΔ2–60
mutant) and pBQ75 (non-epitope tagged Δ2–60 mutant) are at odds
with previous studies reported by this laboratory with a non-epitope
tagged CL synthase Δ2–60 mutant, which showed activity in vitro but
not in vivo [14]. It is possible that pDG5, the previously constructed
plasmid with a non-epitope tagged CL synthase, had an additional
alteration. Unfortunately, this possibility cannot be tested because the
plasmid pDG5 was lost on storage.
Four of the conserved residues in bacterial CL synthases are also
conserved in E. coli and other gram-negative bacterial leader
2112 B.R. Quigley, B.E. Tropp / Biochimica et Biophysica Acta 1788 (2009) 2107–2113peptidases. These conserved residues, L7, V8, R32, and G59, were
replaced by site-directed mutagenesis to determine if they are
required for CL synthase processing or function.
The mutation G59A did not affect CL synthase processing and had
little if any effect on enzyme activity. The G59 residue was the least
highly conserved residue in the leader peptidase. It was missing from
two of the nine bacterial leader peptidases that were analyzed. The
R31 and R32 residues are highly conserved in CL synthases produced
by gram-negative bacteria. ClustalW analysis reveals that the
comparable leader peptidase residue, which is located at position-
34, is either arginine or lysine in the nine gram-negative bacteria
analyzed. The K30 residue in E. coli CL synthase is also conserved in
the gram-negative bacteria analyzed. Because it seemed possible that
one of these basic residues might be able to compensate for the loss
of the others, all three residues were converted to threonines in
plasmid pBQ70. The fact that converting residues 30–32 to threonines
leads to the production of a protein that undergoes altered
posttranslational processing and has much lower in vivo and in vitro
activity than the parent protein with three basic residues suggests
that at least one of the basic residues is required for correct CL
synthase processing and full enzyme activity.
The LV7-8SS mutation present in plasmid pBQ72 replaces two
conserved hydrophobic residues in the ﬁrst transmembrane region of
CL synthasewith polar uncharged residues of similar side chain length.
The resulting CL synthasemigrates at an increased apparentmolecular
mass relative to the EE tagged CL synthase encoded by pBQ43.
Moreover, the mutant protein is only slightly active in vivo, but fully
active in vitro. In fact, membranes isolated from IPTG induced DG6/
pBQ72 have greater CL synthase activity than membranes isolated
from IPTG induced DG6/pBQ43 (Table 4). The loss of in vivo activity
observed for the LV7-8SS mutant appears to be speciﬁc because LI19-
20SS and II52-53SS mutants retain activity (B. R. Quigley in The N-
terminal sequence of E. coli CL synthase: function(s) of the conserved
residues. Ph.D. Thesis, City University of New York, 2007). It is difﬁcult
to reconcile the fact that the LV7-8SSmutant loses in vivo activitywhile
the Δ2–60 deletion mutant retains it. Perhaps the answer relates to a
contribution made by some other amino acid(s) in the 2–60 segment.
Shibuya et al. have demonstrated that the catalytic site of CL
synthase is located on the periplasmic side of the cell membrane [15].
The results of experiments performed in the present study suggest
that the CL synthase mutant protein with serine substitutions at
positions 7 and 8 inserts incorrectly into the cell membrane so that its
catalytic site faces the cytoplasm. Such an incorrect insertion for the
mutant enzyme is supported by preliminary experiments in which
intact DG6/pBQ43 and DG6/pBQ72 spheroplasts were subjected to
trypsin digestion. Considerable EE tagged CL synthase was digested
when intact DG6/pBQ43 spheroplasts were treated with trypsin but
not when intact DG6/pBQ72 spheroplasts were treated (Quigley, B.R.
and Tropp, B.E., unpublished data).
It is possible that the CL synthase N-terminal region is initially
inserted in thecellmembrane in thesamewayas the leaderpeptidaseN-
terminal region but is then cleaved.However, if this iswhat happens, it is
difﬁcult to see how CL synthase retains its association with the cell
membrane or how the Δ2–60 CL synthase mutant remains associated
with the cell membrane. One possibility is that CL synthase is subjected
to some type of posttranslational modiﬁcation in which a hydrophobic
group is attached to the protein.
These studies show thatmutations to conserved residues within the
N-terminus of CL synthase result in structural and functional alterations
in CL synthase. CL synthase with the mutation LV7-8SS, encoded by
pBQ72,migrates at an increased apparentmolecularmass relative to the
EE epitope tagged CL synthase encoded by pBQ43, and has activity in
vitro but very little activity in vivo, suggesting that the protein exists in
the cell with an altered membrane topology. It would be interesting to
determine if a comparablemutation in thebacterial leaderpeptidasehas
a similar effect on protein topology.Acknowledgements
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